Sana Biotechnology, Inc.
Biotechnology company · Seattle, Washington, United States · Nasdaq: SANA
Sana Biotechnology, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker SANA. It has reported private securities offerings to the US SEC, most recently $821 million sold in a notice filed in 2020.
Sana Biotechnology at a glance
What does Sana Biotechnology do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $821.1 million sold (2020).
Frequently asked questions about Sana Biotechnology
Where is Sana Biotechnology headquartered?
Sana Biotechnology, Inc. is headquartered in Seattle, Washington, United States.
What does Sana Biotechnology do?
Sana Biotechnology, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Sana Biotechnology a public company?
Yes. Sana Biotechnology, Inc. trades on Nasdaq under the ticker SANA.
When was Sana Biotechnology founded?
The earliest incorporation on record for Sana Biotechnology, Inc. is in 2018, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.